Results 1 to 10 of about 34,164 (162)

Diagnosis for Chinese patients with light chain amyloidosis: a scoping review

open access: yesAnnals of Medicine, 2023
Background Amyloid light chain (AL) amyloidosis is the most common systemic amyloidosis. The objective of this scoping review was to map the available literature on the diagnosis of AL amyloidosis in China.Materials and Methods The published academic ...
Meilan Chen   +9 more
doaj   +3 more sources

Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis [PDF]

open access: yesJACC: Basic to Translational Science, 2019
Summary: Cardiac amyloidosis is a restrictive cardiomyopathy that results from the deposition of misfolded light chain or transthyretin proteins, most commonly, in cardiac tissue.
Kathleen W. Zhang, MD   +2 more
doaj   +3 more sources

Cutaneous light chain amyloidosis with multiple myeloma: A concise review

open access: yesHematology/Oncology and Stem Cell Therapy, 2019
Objective/Background: Cutaneous immunoglobulin (Ig) amyloid light-chain (AL) amyloidosis associated with overt multiple myeloma (MM) is rare and optimal treatment is not well defined.
Mirela Andrei, Jen Chin Wang
doaj   +3 more sources

An atypical cause of amyloidosis: a case of combined heavy and light chain amyloidosis [PDF]

open access: yesBMC Nephrology
Background The International Society of Amyloidosis recognizes 15 types of kidney-related amyloidosis, with most studies identifying immunoglobulin light chain (AL) amyloidosis as the leading cause in over half of these cases.
Dina R. Gonzalez-Hernandez   +2 more
doaj   +2 more sources

Light-chain amyloidosis with dysphagia as the main symptom: a case report [PDF]

open access: yesJournal of Medical Case Reports
Background Immunoglobulin light-chain amyloidosis is a relatively rare condition with a worldwide incidence of 5.1–12.8 cases per million person-years (Baker, 2022).
Maomao Ai   +5 more
doaj   +2 more sources

Strong positive light chain immunostaining in a patient with transthyretin amyloidosis

open access: yesHematology, 2023
The two most common systemic amyloidosis types are immunoglobulin light chain (AL) and amyloid transthyretin (ATTR) amyloidosis, in which the precursor proteins responsible for amyloidosis are light chain and transthyretin, respectively.
Jiao Chen   +5 more
doaj   +1 more source

Amyloid light-chain deposition in a schwannoma

open access: yesInterdisciplinary Neurosurgery, 2021
Systemic amyloid light-chain amyloidosis is a protein misfolding disorder characterized by extracellular deposition of amyloid fibrils derived from abnormal clonal immunoglobulin light chains in various organ systems.
Megan M. Jack   +6 more
doaj   +1 more source

A Case of Localized Amyloid Light-Chain Amyloidosis in the Small Intestine [PDF]

open access: yesIntestinal Research, 2014
Amyloidosis is characterized by the abnormal deposition of extracellular amyloid fibrils. Cases involving amyloid light-chain amyloidosis in the small intestine have been reported infrequently in Korea.
Jong Hyo Choi   +7 more
doaj   +1 more source

Restrictive Atrial Dysfunction in Cardiac Amyloidosis: Differences between Immunoglobulin Light Chain and Transthyretin Cardiac Amyloidosis Patients

open access: yesBiomedicines, 2022
Background: In cardiac amyloidosis, the prevalence of thromboembolic events and atrial fibrillation is higher in transthyretin amyloidosis compared to immunoglobulin light chain amyloidosis.
Mathijs O. Versteylen   +3 more
doaj   +1 more source

Diverse patterns of antibody variable gene repertoire disruption in patients with amyloid light chain (AL) amyloidosis.

open access: yesPLoS ONE, 2020
Immunoglobulin light chain amyloidosis is the most common form of systemic amyloidosis. AL amyloidosis is caused by a misfolded light chain produced by a clonal population of plasma cells.
Elaine C Chen   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy